Using tumor organoids to guide liver cancer treatment
Treatments studied
Part of Cancer clinical trials.
This trial tests whether growing your tumor cells in a lab (organoids) can help pick the best drug for your advanced liver cancer. It aims to make treatment more personalized and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 70 with a confirmed diagnosis of primary liver cancer that cannot be removed with surgery.
- A life expectancy of at least 6 months and good day-to-day function (able to care for self, up and about).
- Adequate liver, kidney, and blood cell counts as shown by routine lab tests.
- No cancer treatment, including radiation, within the past 2 to 12 weeks, depending on the type.
- No other serious medical conditions like out of control infections, heart problems, or bleeding disorders.
- Agree to use effective birth control during the study and for several months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized treatment plan based on a lab-grown 3D model of your tumor (called an organoid) can help prevent your liver cancer from coming back after surgery. The goal is to find the most effective drugs for your specific cancer.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This trial uses a lab-grown model of your tumor (an organoid) to test which drugs work best before giving them to you. If you cannot have surgery to remove your cancer, this approach may help find a more effective treatment.
This study uses tumor samples to create lab-grown mini-livers (organoids) to better understand liver cancer. It may help researchers learn more about the disease and develop new treatments.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This study is testing whether combining targeted therapy with immunotherapy can help people with advanced liver cancer that cannot be surgically removed. The goal is to see if this combination treatment is safe and effective.
Hear when a new Unresectable Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.